Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs
暂无分享,去创建一个
G. Valk | M. Intven | G. Meijer | M. Vriens | J. M. de Laat | H. Eijkelenkamp | Eline N. M. van Vliembergen